Nuveen Asset Management, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2024$182,306
-40.8%
55,922
-43.8%
0.00%
Q1 2022$308,000
+8.8%
99,587
+0.0%
0.00%
Q4 2021$283,000
-62.5%
99,561
-8.9%
0.00%
Q3 2021$754,000
-26.3%
109,269
-1.9%
0.00%
Q2 2021$1,023,000
-56.9%
111,404
-54.4%
0.00%
-100.0%
Q1 2021$2,376,000
+63.6%
244,367
+72.8%
0.00%
Q4 2020$1,452,000
+2.0%
141,450
+0.2%
0.00%
-100.0%
Q3 2020$1,424,000
-69.7%
141,183
-68.7%
0.00%
-50.0%
Q2 2020$4,706,000
+16.3%
451,140
-5.9%
0.00%0.0%
Q1 2020$4,047,000
-63.9%
479,528
-62.5%
0.00%
-50.0%
Q4 2019$11,202,000
-10.5%
1,280,288
+10.2%
0.00%
-20.0%
Q3 2019$12,511,000
+62.1%
1,162,241
+91.4%
0.01%
+66.7%
Q2 2019$7,716,000
+207.2%
607,125
+5606.6%
0.00%
-78.6%
Q1 2015$2,512,000
+44.4%
10,639
+15.7%
0.01%
+40.0%
Q4 2014$1,740,000
-18.7%
9,194
+2.5%
0.01%
-23.1%
Q3 2014$2,139,000
+35.8%
8,967
-40.7%
0.01%
+44.4%
Q1 2014$1,575,000
+226.8%
15,126
+224.9%
0.01%
+200.0%
Q4 2013$482,0004,6550.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$13,338,0002.17%
Camber Capital Management LP 2,555,000$26,214,0000.92%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,959,741$40,627,0000.80%
Palo Alto Investors LP 1,373,897$14,096,0000.74%
Sofinnova Investments, Inc. 629,650$6,460,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 604,937$6,207,0000.22%
J. Goldman & Co LP 238,617$2,448,0000.12%
GLOBEFLEX CAPITAL L P 55,027$565,0000.12%
FRED ALGER MANAGEMENT, LLC 3,416,003$35,048,0000.09%
JUPITER ASSET MANAGEMENT LTD 728,440$7,474,0000.08%
View complete list of PUMA BIOTECHNOLOGY INC shareholders